Evidence map›Paper›PMID 42564273›Full record

ArticleFrontiers in microbiology2026

Integron architecture and virulence-associated gene profiles in extensively drug-resistant high-risk

José Luis Fernández-Vázquez, Ma Dolores Jarillo-Quijada, Santiago Castillo-Ramírez, María Luisa Hernández-Medel, Manuelita Zavala-Pineda, Mónica Osorio-Guzmán, José Ignacio Santos-Preciado, María Dolores Alcántar-Curiel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

José Luis Fernández-VázquezLaboratorio de Infectología, Microbiología e Inmunología Clínicas, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México. Ciudad de México, Mexico.
Ma Dolores Jarillo-QuijadaLaboratorio de Infectología, Microbiología e Inmunología Clínicas, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México. Ciudad de México, Mexico.
Santiago Castillo-RamírezPrograma de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.
María Luisa Hernández-MedelUnidad de Infectología, Hospital General de México Dr. Eduardo Liceaga. Ciudad de México, Mexico.
Manuelita Zavala-PinedaUnidad de Infectología, Hospital General de México Dr. Eduardo Liceaga. Ciudad de México, Mexico.
Mónica Osorio-GuzmánUnidad de Infectología, Hospital General de León, León, Guanajuato, Mexico.
José Ignacio Santos-PreciadoLaboratorio de Infectología, Microbiología e Inmunología Clínicas, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México. Ciudad de México, Mexico.
María Dolores Alcántar-CurielLaboratorio de Infectología, Microbiología e Inmunología Clínicas, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México. Ciudad de México, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Whole-genome sequencing and comparative genomic analyses were performed on four bloodstream Results: Three isolates (Psa/12, Psa/19, and Psa/21) were classified as XDR and belonged to ST309, whereas one isolate (Psa/20) was PDR and assigned to ST233. The ST233 isolate carried the highest number of resistance genes, including the carbapenemase gene Conclusion: XDR high-risk

Indexed as

chromosomal resistance regionsclass 1 integronsExoU/ExoS virulotypesextensively drug-resistanthigh-risk clonesPseudomonas aeruginosaST233ST309

Identifiers

PMID42564273
PMCPMC13442380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.